Translating Innovative Science into Differentiated Therapies
Focused on disciplined discovery and early clinical impact
Drug Development Platform
Research & Development
Our teams and advisors have extensive experience of supporting 11+ approved drugs, and bring deep cross-functional expertise across all elements of drug discovery.
Clinical Development
Our FIH and PoC studies are managed in-house by our top tier clinical operations functions, including patient recruitment, site management, and study monitoring.
Technology
All of our functioning is supported by our integrated tech platform, including data capturing, management, surveillance and analysis.
About Anveta
Anveta Therapeutics is a drug discovery and early clinical development company dedicated to translating innovative academic science into differentiated small-molecule therapeutics. We collaborate closely with academic and institutional partners in India and globally to identify and advance novel targets and mechanisms at early stages, with the potential for first-in-class or best-in-class differentiation.
Our co-development model emphasizes scientific continuity, enabling originating researchers to remain actively engaged as programs advance from discovery through IND-enabling studies and early clinical development.
